Irritable bowel syndrome (IBS) affects 5–10% of the global population. Up to one-third of
people with IBS also experience anxiety or depression. Gastrointestinal and psychological …

The human gut microbiome contains the largest number of bacteria in the body and has the
potential to greatly influence metabolism, not only locally but also systemically. There is an …

Inflammatory Bowel Disease (IBD) includes a spectrum of chronic immune-mediated
intestinal diseases thought to be related to the complex interaction between the host …

The low FODMAP (fermentable oligosaccharide, disaccharide, monosaccharide, and polyol)
diet is a beneficial therapeutic approach for patients with irritable bowel syndrome (IBS) …

Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder
characterized by chronic abdominal pain and altered bowel habits. It can be subclassified in …

Gut microbiota has been reported to be closely related to host energy metabolism and
immunity, and thus influence the development and progression of various human diseases …

Most adverse reactions to food are patient self-reported and not based on validated tests but
nevertheless lead to dietary restrictions, with patients believing that these restrictions will …

Background: A mechanistic understanding of the effects of dietary treatment in irritable
bowel syndrome (IBS) is lacking. Our aim was therefore to investigate how fermentable oligo …

Consumption of high FODMAP (Fermentable Oligo-, Di-, and Monosaccharides and Polyols)
diet is the leading cause of alteration in the human gut microbiome, thereby, causing irritable …

Background: There is limited evidence regarding the use of low FODMAP diet apps. This
study aimed to evaluate the effectiveness of an app intended to reduce symptoms in …